18 results on '"Bhuyan, Prakash K."'
Search Results
2. Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008–2018: The EACH-WOMAN Project
3. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients
4. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates
5. Immunogenicity and safety of a Haemophilus influenzae B (Hib)–hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants
6. Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age
7. Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus– Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age
8. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults >50 years
9. Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL
10. Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults
11. Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population
12. Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
13. Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population.
14. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥ 50 years
15. Safety and Immunogenicity of a Modified Process Hepatitis B Vaccine in Healthy Infants
16. A RANDOMIZED, MULTICENTER, OPEN-LABEL CLINICAL TRIAL TO ASSESS THE ANAMNESTIC IMMUNE RESPONSE 4 TO 8 YEARS AFTER A PRIMARY HEPATITIS B VACCINATION SERIES
17. Short Interfering RNA-Mediated Inhibition of Herpes Simplex Virus Type 1 Gene Expression and Function during Infection of Human Keratinocytes
18. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.